Alana D. Carpenter,^1,2,* Yaoxiang Li,^3,* Oluseyi O. Fatanmi,^1,2 Stephen Y. Wise,^1,2 Sarah A. Petrus,^1,2 Brianna L. Janocha,^1,2 Amrita K. Cheema,^3,4 Vijay K. Singh<sup>1,2,**

1</sup>Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland
²Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, Maryland
³Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
⁴Department of Biochemistry, Molecular and Cellular Biology, Georgetown University Medical Center, Washington DC

^*These authors contributed equally to the study.
^**Corresponding author: Vijay K. Singh, Ph.D., Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD; email: vijay.singh@usuhs.edu.